Clinical studies recruiting near Anchorage

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Alaska Oncology and Hematology · Hoffmann-La Roche · NCT06793215 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Anchorage Associates in Radiation Medicine · Alliance for Clinical Trials in Oncology · NCT07091617 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Providence Alaska Medical Center · Agendia · NCT03053193 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Providence Alaska Medical Center · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Alaska Oncology and Hematology · Pfizer · NCT07144280 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Alaska Oncology and Hematology ( Site 0039) · Merck Sharp & Dohme LLC · NCT06077760 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Alaska Heart Institute · Bristol-Myers Squibb · NCT05489705 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site US016 · Incyte Corporation · NCT07522073 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Anchorage Associates in Radiation Medicine · National Cancer Institute (NCI) · NCT04269902 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Alaska Oncology and Hematology, Llc · BeOne Medicines · NCT07492641 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Anchorage Associates in Radiation Medicine · Canadian Cancer Trials Group · NCT06592924 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Anchorage Associates in Radiation Medicine · SWOG Cancer Research Network · NCT05806515 STOP AF First Post-Approval Study
Phase N/A · Alaska Heart Institute · Medtronic Cardiac Ablation Solutions · NCT05227053 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Anchorage Associates in Radiation Medicine · Alliance for Clinical Trials in Oncology · NCT04242095 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Alaska Womens Cancer Care · Canadian Cancer Trials Group · NCT05640999 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Alaska Women's Cancer Care · National Cancer Institute (NCI) · NCT05256225 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site US10052 · Astellas Pharma Global Development, Inc. · NCT02960022 Project: Every Child for Younger Patients With Cancer
Phase N/A · Providence Alaska Medical Center · Children's Oncology Group · NCT02402244 The Alaska Oculocardiac Reflex Study
Phase N/A · Alaska Children's EYE & Strabismus · Alaska Blind Child Discovery · NCT04353960 A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · Alaska Oncology and Hematology · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Anchorage Associates in Radiation Medicine · ECOG-ACRIN Cancer Research Group · NCT04566328 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Providence Alaska Medical Center · Children's Oncology Group · NCT05235165 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Anchorage Associates in Radiation Medicine · Alliance for Clinical Trials in Oncology · NCT05677490 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Alaska Women's Cancer Care · National Cancer Institute (NCI) · NCT07198074 The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
NA · Providence Alaska Medical Center · Mayo Clinic · NCT06087224 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Katmai Oncology Group · National Cancer Institute (NCI) · NCT06058377 A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V60
Phase 2 · Anchorage Associates in Radiation Medicine · SWOG Cancer Research Network · NCT04511013 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Anchorage Associates in Radiation Medicine · ECOG-ACRIN Cancer Research Group · NCT04239573

Look up another city

Look up another condition